Fig. 1From: Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changesA The in vitro release rate of CUR and PTX encapsulated in CUR@L, CUR-PTX@PEG-L, and CUR-PTX@GE11-L. B–D The morphology observation of CUR@L, CUR-PTX@PEG-L, and CUR-PTX@GE11-L by Cryo-TEMBack to article page